Lv1
60 积分 2024-05-10 加入
Evolution of low HER2 expression between early and advanced-stage breast cancer
8天前
已完结
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
9天前
已完结
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
13天前
已完结
FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations
2个月前
已完结
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
3个月前
已完结
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
3个月前
已完结
Hodgkin lymphoma: 2025 update on diagnosis, risk‐stratification, and management
5个月前
已完结
PD-1 and PD-L1 Immunohistochemistry as a Diagnostic Tool for Classic Hodgkin Lymphoma in Small-volume Biopsies
5个月前
已完结
Diagnostic Utility of STAT6 and pSTAT6 Immunohistochemistry for Distinguishing Classic Hodgkin Lymphoma and Peripheral T-Cell Lymphoma With Hodgkin and Reed-Sternberg–like Cells
5个月前
已完结
Expression profile and prognostic value of glypican‐3 in post‐operative South Korean hepatocellular carcinoma patients
5个月前
已完结
皖公网安备34019202002308
